IronBridge Capital Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$7.49M Buy
212,822
+90,830
+74% +$2.88M 0.45% 75
2016
Q4
$3.76M Sell
121,992
-1,069
-0.9% -$33.1K 0.17% 131
2016
Q3
$3.71M Buy
123,061
+24,792
+25% +$748K 0.17% 134
2016
Q2
$2.69M Buy
+98,269
New +$2.51M 0.12% 148

Other funds holding RGEN

IronBridge Capital Management's RGEN Position: Q1 2017 in Review

IronBridge Capital Management increased its Repligen (RGEN) stake by 74% in Q1 2017, buying an estimated $2.88M and bringing the position to 212,822 shares worth $7.49M. The position accounts for 0.45% of the portfolio, ranked #75.

IronBridge Capital Management first reported a position in RGEN in Q2 2016 and has held it in 4 quarters since. 180 funds tracked by Wall St. Rank hold RGEN as of Q1 2017.

  • IronBridge Capital Management held 212,822 shares of Repligen worth $7.49M as of Q1 2017.
  • IronBridge Capital Management bought 90,830 Repligen shares in Q1 2017, an estimated $2.88M.
  • Repligen made up 0.45% of IronBridge Capital Management's portfolio in Q1 2017, its #75 holding.
  • IronBridge Capital Management first reported a position in Repligen in Q2 2016 and has held it in 4 quarters since.
  • 180 funds tracked by Wall St. Rank held Repligen as of Q1 2017.

Based on IronBridge Capital Management's 13F filing for Q1 2017, filed 10 May 2017.